{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:00:28Z","timestamp":1778155228901,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10157-018-1622-y","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T02:24:41Z","timestamp":1536891881000},"page":"182-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Influence of chronic kidney disease and worsening renal function on clinical outcomes in patients undergoing primary percutaneous coronary intervention"],"prefix":"10.1007","volume":"23","author":[{"given":"Toshijiro","family":"Aoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ichimiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Kanashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"1622_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow MG, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305.","journal-title":"N Engl J Med"},{"key":"1622_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ijcard.2012.01.097","volume":"167","author":"HF AlFaleh","year":"2013","unstructured":"AlFaleh HF, Alsuwaida AO, Ullah A, et al. The prognostic impact of in-hospital worsening of renal function in patients with acute coronary syndrome. Int J Cardiol. 2013;167:866\u201370.","journal-title":"Int J Cardiol"},{"key":"1622_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.ahj.2010.08.007","volume":"160","author":"AP Amin","year":"2010","unstructured":"Amin AP, Spertus JA, Reid KJ, et al. The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality. Am Heart J. 2010;160:1065\u201371.","journal-title":"Am Heart J"},{"key":"1622_CR4","doi-asserted-by":"publisher","first-page":"e002475","DOI":"10.1161\/CIRCINTERVENTIONS.114.002475","volume":"8","author":"D Giacoppo","year":"2015","unstructured":"Giacoppo D, Madhavan MV, Baber U, et al. Impact of contrast-induced acute kidney injury after percutaneous coronary intervention on short- and long-term outcomes: pooled analysis from the HORIZONS-AMI and ACUITY trials. Circ Cardiovasc Interv. 2015;8:e002475.","journal-title":"Circ Cardiovasc Interv"},{"key":"1622_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCINTERVENTIONS.111.963264","volume":"4","author":"JA Goldstein","year":"2011","unstructured":"Goldstein JA, Maini B, Dixon SR, et al. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv. 2011;4:429\u201337.","journal-title":"Circ Cardiovasc Interv"},{"key":"1622_CR6","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"1622_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713\u201335.","journal-title":"Am J Kidney Dis"},{"key":"1622_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.ajkd.2007.05.008","volume":"50","author":"A Levin","year":"2007","unstructured":"Levin A, Warnock DG, Mehta RL, et al. Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis. 2007;50:1\u20134.","journal-title":"Am J Kidney Dis"},{"key":"1622_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/j.ajkd.2012.01.016","volume":"59","author":"EH Bae","year":"2012","unstructured":"Bae EH, Lim SY, Cho KH, et al. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea acute myocardial infarction registry. Am J Kidney Dis. 2012;59:795\u2013802.","journal-title":"Am J Kidney Dis"},{"key":"1622_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/01.ASN.0000034200.82278.DC","volume":"13","author":"CY Hsu","year":"2002","unstructured":"Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2002;13:504\u201310.","journal-title":"J Am Soc Nephrol"},{"key":"1622_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","volume":"39","author":"P Raggi","year":"2002","unstructured":"Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39:695\u2013701.","journal-title":"J Am Coll Cardiol"},{"key":"1622_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7326\/0003-4819-140-1-200401060-00006","volume":"140","author":"P Munttner","year":"2004","unstructured":"Munttner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004;140:9\u201317.","journal-title":"Ann Intern Med"},{"key":"1622_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jjcc.2014.12.005","volume":"66","author":"N Murata","year":"2015","unstructured":"Murata N, Kaneko H, Yajima J, et al. The prognostic impact of worsening renal function in Japanese patients undergoing percutaneous coronary intervention with acute coronary syndrome. J Cardiol. 2015;66:326\u201332.","journal-title":"J Cardiol"},{"key":"1622_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijcard.2010.10.024","volume":"155","author":"G Lazaros","year":"2012","unstructured":"Lazaros G, Tsiachris D, Tousoulis D, et al. In-hospital worsening renal function is an independent predictor of one-year mortality in patients with acute myocardial infarction. Int J Cardiol. 2012;155:97\u2013101.","journal-title":"Int J Cardiol"},{"key":"1622_CR15","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/ejhf.609","volume":"18","author":"K Damman","year":"2016","unstructured":"Damman K, Solomon SD, Pfeffer MA, et al. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme. Eur J Heart Fail. 2016;18:1508\u201317.","journal-title":"Eur J Heart Fail"},{"key":"1622_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijcard.2006.06.044","volume":"118","author":"JJ Ferrer-Hita","year":"2007","unstructured":"Ferrer-Hita JJ, Dominguez-Rodriguez A, Garcia-Gonzalez MJ, Abreu-Gonzalez PA. Renal dysfunction is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Int J Cardiol. 2007;118:243\u20135.","journal-title":"Int J Cardiol"},{"key":"1622_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ahj.2014.08.016","volume":"168","author":"A Krishnamoorthy","year":"2014","unstructured":"Krishnamoorthy A, Greiner MA, Sharma PP, et al. Transient and persistent worsening renal function during hospitalization for acute heart failure. Am Heart J. 2014;168:891\u2013900.","journal-title":"Am Heart J"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1622-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1622-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1622-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T23:22:10Z","timestamp":1568416930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1622-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1622-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]},"assertion":[{"value":"9 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"H.I. received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Daiichi-Sankyo Pharma Inc. and MSD K.K. T. M. received lecture fees from Bayel Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Pfizer Japan Inc., Sanofi-aventis K.K., and Takeda Pharmaceutical Co., Ltd. T.M.received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc, Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K.K., Takeda Pharmaceutical Co., Ltd., Teijin Pharma Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number 2011-1139 in Nagoya University Hospital and 2010-7 in Yokkaichi Municipal Hospital) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}